Bio-Rad is a leading provider of innovative technologies for life science research and clinical diagnostics, leveraging over 70 years of expertise in the field. One of their notable products is the Vericheck ddPCR Empty-Full Capsid Kit, which allows for the simultaneous measurement of adeno-associated virus (AAV) empty-full capsid ratios and viral titers with high precision. This kit is particularly beneficial for gene therapy research, as it requires only a small sample volume and provides quick turnaround times, making it ideal for various stages of AAV vector development and manufacturing. The technology behind this kit, Droplet Digital PCR (ddPCR), enables absolute quantification, ensuring reliable results that are critical for maintaining quality in gene therapy applications.

In addition to their advancements in digital PCR, Bio-Rad offers a comprehensive range of products and solutions for quality control (QC) in laboratory settings. Their QC workflow solutions encompass everything from setup to data analysis, helping laboratories maintain reliable patient test results. Bio-Rad's commitment to quality is evident in their training resources and best practices for laboratory management, which are designed to optimize QC procedures and ensure compliance with regulatory standards. Their diverse product offerings, including chromatography columns and imaging systems, further support researchers and clinicians in achieving accurate and efficient results across various applications in life sciences.

United States

Research & Diagnostic Products. Bio-Rad is partnering with Biodesix on a test for SARS-CoV-2.EUA (05/2020) for a digital PCR molecular diagnostic test for SARS-CoV-2, the virus that causes coronavirus disease COVID-19. The 2019-nCoV CDC ddPCR Triplex Probe Assay is now authorized for use on the firm's QX200 and QXDx Droplet Digital PCR systems.

Bio-Rad

Company Details